These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 13864822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S.
    Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348
    [No Abstract] [Full Text] [Related]

  • 4. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES.
    Can Psychiatr Assoc J; 1962 Apr; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract] [Full Text] [Related]

  • 5. Combined tranylcypromine-trifluoperazine therapy in obstetrics and gynaecology.
    PRUETER GW.
    Can Psychiatr Assoc J; 1962 Apr; 7(Suppl)():77-83. PubMed ID: 14489022
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F.
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical study of a potent antidepressant: tranylcypromine with trifluoperazine in the aged chronically ill.
    STRAKER M, GRAUER H.
    Can Psychiatr Assoc J; 1962 Sep; 7(Supl)():96-103. PubMed ID: 13917604
    [No Abstract] [Full Text] [Related]

  • 11. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H, ERICKSON RW.
    Arch Int Pharmacodyn Ther; 1962 Feb 01; 135():407-25. PubMed ID: 13901404
    [No Abstract] [Full Text] [Related]

  • 12. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM.
    Can Psychiatr Assoc J; 1962 Feb 01; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined tranlcypromine and trifluoperazine therapy in general medicine.
    LEWIS RA.
    Can Psychiatr Assoc J; 1962 Feb 01; 7(Suppl)():74-6. PubMed ID: 14464901
    [No Abstract] [Full Text] [Related]

  • 15. Experiences with N, N-dimethyl-2-phenylcyclo-propylamine in chronic anergic schizophrenic patients.
    KURLAND AA, McCUSKER K.
    J Neuropsychiatr; 1962 Feb 01; 3():190-4. PubMed ID: 14460738
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase.
    TEDESCHI RE, TEDESCHI DH, AMES PL, COOK L, MATTIS PA, FELLOWS EJ.
    Proc Soc Exp Biol Med; 1959 Nov 01; 102():380-1. PubMed ID: 13837261
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tranylcypromine in the treatment of chronic schizophrenics.
    BARSA JA, SAUNDERS JC.
    Am J Psychiatry; 1962 Apr 01; 118():933-4. PubMed ID: 13865333
    [No Abstract] [Full Text] [Related]

  • 20. Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase.
    Yoshida S, Meyer OG, Rosen TC, Haufe G, Ye S, Sloan MJ, Kirk KL.
    J Med Chem; 2004 Mar 25; 47(7):1796-806. PubMed ID: 15027872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.